TXNRD1 Antikörper (AA 1-497)

Produktnummer ABIN7172018

Produktdetails anti-TXNRD1 Antikörper

Target: TXNRD1 (Thioredoxin Reductase 1 (TXNRD1))

Bindungsspezifität: AA 1-497

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TXNRD1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Thioredoxin reductase 1, cytoplasmic protein (1-497AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu TXNRD1

Target: TXNRD1 (Thioredoxin Reductase 1 (TXNRD1))

Andere Bezeichnung: TXNRD1 (TXNRD1 Produkte)

Synonyme: TrxR1 antikoerper, cb682 antikoerper, fb83a08 antikoerper, wu:fb83a08 antikoerper, GB14972 antikoerper, MGC85342 antikoerper, NADPH-dependent thioredoxin reductase C antikoerper, T32G6.20 antikoerper, T32G6_20 antikoerper, GRIM-12 antikoerper, TR antikoerper, TR1 antikoerper, TRXR1 antikoerper, TXNR antikoerper, Tr antikoerper, thioredoxin reductase 1 antikoerper, thioredoxin reductase 1 L homeolog antikoerper, NADPH-dependent thioredoxin reductase C antikoerper, ThioRedoXin Reductase antikoerper, TXNRD1 antikoerper, txnrd1 antikoerper, Trxr-1 antikoerper, txnrd1.L antikoerper, NTRC antikoerper, trxr-1 antikoerper, Txnrd1 antikoerper

Hintergrund:

Background: Isoform 1 may possess glutaredoxin activity as well as thioredoxin reductase activity and induces actin and tubulin polymerization, leading to formation of cell membrane protrusions. Isoform 4 enhances the transcriptional activity of estrogen receptors alpha and beta while isoform 5 enhances the transcriptional activity of the beta receptor only. Isoform 5 also mediates cell death induced by a combination of interferon-beta and retinoic acid.

Aliases: cytoplasmic antibody, Gene associated with retinoic and IFN-induced mortality 12 protein antibody, Gene associated with retinoic and interferon-induced mortality 12 protein antibody, Gene associated with retinoid IFN induced mortality 12 protein antibody, GRIM 12 antibody, GRIM-12 antibody, GRIM12 antibody, KDRF antibody, KM 102 derived reductase like factor antibody, KM-102-derived reductase-like factor antibody, MGC9145 antibody, Oxidoreductase antibody, Thioredoxin reductase 1 antibody, Thioredoxin reductase 1 cytoplasmic antibody, Thioredoxin reductase GRIM 12 antibody, Thioredoxin reductase TR1 antibody, TR 1 antibody, TR antibody, TR1 antibody, TRXR 1 antibody, TRXR1 antibody, TRXR1_HUMAN antibody, TXNR antibody, TXNRD 1 antibody, Txnrd1 antibody

UniProt: Q16881

Pathways: Regulation of Lipid Metabolism by PPARalpha, Regulation of Carbohydrate Metabolic Process, Cell RedoxHomeostasis